US Patent Issued to ProMab Biotechnologies, Forevertek Biotechnology on Jan. 20 for "Humanized BCMA antibody and BCMA-CAR-T cells" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,873, issued on Jan. 20, was assigned to ProMab Biotechnologies Inc. (Richmond, Calif.) and Forevertek Biotechnology Co. Ltd (Changsha, China).

"Humanized BCMA antibody and BCMA-CAR-T cells" was invented by Lijun Wu (Berkeley, Calif.) and Vita Golubovskaya (Pinole, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to a humanized BCMA single-chain variable fragment (scFv), comprising VH having the amino acid sequence of SEQ ID NO: 4 and VL having the amino acid sequence of SEQ ID NO: 5. The present invention is also directed to a BCMA chimeric antigen receptor fusion protein comprising from N-terminus to C-terminu...